hims hers glp 1 & stock drops 30% after Novo Nordisk terminates deal Weight Loss Care for Women,

(2013) 8:e58445

[DOI] [PubMed] [Google Scholar] 31.Kopp K.O., Glotfelty E.J., Li Y., Greig N.H

doi: 10.1016/j.bbrc.2018.10.197 66 WuXLiSXuePLiY

S3D, GLP-1RA intervention was associated with a reduction in insulin levels at 2 h after OGTT when compared to metformin (MD = 22.18

Niazi explains that tirzepatide is a newer dual-agonist that targets both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, which he says offers superior metabolic regulation and appetite suppression. Mounjaro is currently FDA-approved for type 2 diabetes, and Zepbound is also FDA-approved for weight loss

Accessed August 5, 2025.